A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses
Mulloy, R. P.; Evseev, D.; Bui-Marinos, M. P.; Sharlin, N.; Corcoran, J. A.
Show abstract
Viruses face a selective pressure to evade cellular antiviral responses to control the outcome of an infection. However, due to their limited genome size, viruses must adopt unique strategies to confront cellular sensors. Since emerging in humans, SARS-CoV-2 has accrued multiple mutations throughout its genome, some of which enhanced virus replication and led to the rise of viral variants. However, the biological consequences of many of these changes remain to be discovered. Here, we show that SARS-CoV-2 produces a truncated form of the nucleocapsid protein, called N*M210. Due to the acquisition of a viral transcription regulatory sequence (TRS) in the N gene, certain variants, such as Omicron, produce a new viral mRNA that markedly increases N*M210 expression. We show that N*M210 is a dsRNA binding protein, which inhibits multiple arms of the cellular antiviral response, including blocking interferon induction and inhibiting stress granule formation. We created a panel of recombinant SARS-CoV-2 viruses (rSARS-2) with mutations in the N gene that increased or decreased N*M210 production. We show that N*M210 production increases virus fitness, as viruses that produce more N*M210 outcompeted wild-type rSARS-2. We demonstrate that the fitness advantage provided by N*M210 is partly due to its ability to potently block stress granules. We propose a model where, to evade the cellular antiviral response, SARS-CoV-2 has evolved a mechanism to increase the production of a truncated form of the N protein, which broadly limits the activation of dsRNA-induced antiviral responses, tipping the balance in favour of the virus in the battle for control of the cell. O_FIG O_LINKSMALLFIG WIDTH=173 HEIGHT=200 SRC="FIGDIR/small/638421v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@98766dorg.highwire.dtl.DTLVardef@186f69eorg.highwire.dtl.DTLVardef@1a903f4org.highwire.dtl.DTLVardef@142c799_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LISARS-CoV-2 variants evolved to upregulate truncated N (N*) synthesis to increase virus fitness C_LIO_LIN*M210 is a potent dsRNA-binding protein that blocks cellular dsRNA sensing C_LIO_LIN*M210 inhibits stress granule formation independent of G3BP1 binding C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Library-based analysis reveals segment and length dependent characteristics of defective influenza genomes 97%
- TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction 97%
- SARS-CoV-2 nucleocapsid protein inhibits the PKR-mediated integrated stress response through RNA-binding domain N2b 97%
Similar papers in this journal
- Viral-Induced Alternative Splicing of Host Genes Promotes Influenza Replication 98%
- Antiviral function and viral antagonism of the rapidly evolving dynein activating adapter NINL 98%
- The Relative Binding Position of Nck and Grb2 Adaptors Dramatically Impacts Actin-Based Motility of Vaccinia Virus 98%
Similar papers in this journal
- Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell 98%
- Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2 97%
- MHC class Ia molecules facilitate MCK2-dependent MCMV infection of macrophages and virus dissemination to the salivary gland 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.